AVANIR PHARMACEUTICALS INC's ticker is AVNR and the CUSIP is 05348P401. A total of 144 filers reported holding AVANIR PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $5,608,000 | +53.9% | 330,850 | +8.2% | 0.01% | +66.7% |
| Q3 2014 | $3,644,000 | +150.3% | 305,700 | +18.4% | 0.00% | +200.0% |
| Q2 2014 | $1,456,000 | +65.1% | 258,100 | +7.4% | 0.00% | 0.0% |
| Q1 2014 | $882,000 | -1.7% | 240,300 | -10.0% | 0.00% | 0.0% |
| Q4 2013 | $897,000 | -20.8% | 267,000 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $1,132,000 | -4.9% | 267,000 | +3.2% | 0.00% | 0.0% |
| Q2 2013 | $1,190,000 | – | 258,617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JAY JEFFREY R | 258,600 | $1,190,000 | 0.94% |
| BVF INC/IL | 1,006,053 | $4,628,000 | 0.90% |
| Artal Group S.A. | 2,750,000 | $12,650,000 | 0.40% |
| Baker Brothers Advisors | 3,578,591 | $16,462,000 | 0.33% |
| EAM Investors, LLC | 237,017 | $1,090,000 | 0.24% |
| Opus Trading Fund LLC | 23,888 | $110,000 | 0.21% |
| FORTALEZA ASSET MANAGEMENT INC/ | 61,795 | $284,000 | 0.16% |
| CR Intrinsic Investors, LLC | 898,538 | $4,133,000 | 0.14% |
| TimesSquare Capital Management, LLC | 4,261,478 | $19,603,000 | 0.12% |
| Lyons Wealth Management, LLC. | 25,340 | $116,000 | 0.12% |